SCIEX announced today that Aarhus University Hospital in Denmark has invested in SCIEX QTRAP 6500 technology to develop novel mass spectrometry-based assays for clinical research laboratories. Scientists at the hospital’s Department of Clinical Biochemistry are using the QTRAP 6500 LC-MS/MS system for advanced clinical research, due to its exceptional sensitivity and selectivity, which are…
In a proof-of-concept study at Johns Hopkins, researchers have shown that results of common and routine blood tests are not affected by up to 40 minutes of travel on hobby-sized drones.
In the battle against cancer, which kills nearly 8 million people worldwide each year, doctors have in their arsenal many powerful weapons, including various forms of chemotherapy and radiation. What they lack, however, is good reconnaissance — a reliable way to obtain real-time data about how well a particular therapy is working for any given patient.
NHS trusts under the most serious financial pressures are the least likely to be able to terminate expensive private sector deals, warns an expert in The BMJ this week.
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer, is reported in the research journal Nature Methods.
40 years after the launch of its first series model, Siretom, Siemens Healthcare is looking back on the successful development of its computed tomography division. With innovations such as Spiral, Multislice, and most recently Dual Source technology, Siemens has been driving the CT market and clinical diagnostics for decades. Today, three patients are scanned with a Siemens CT system every…
Autografts, the gold standard of bone grafts, have several limitations. As a result, new orthobiologics products are being developed for the benefit of patients as well as surgeons. Innovations in biomaterials and graft design have enabled these advanced products that mimic the natural human bone and speed up bone repair and regeneration.
With its previous LCMS-8030, LCMS-8040 and LCMS-8050 triple-quadrupole systems, Shimadzu has set leading standards in terms of speed, sensitivity and functional design. With the introduction of the new LCMS-8060 (Figure 1), the success story of the LCMS-triple-quadrupole family reaches another milestone.
Zenon's Doc-db is a full-fledged document management system which has been internationally available since 2006.
Wallace Coulter, one of the founders of Beckman Coulter, was motivated by a belief that science should serve humanity. This was the inspiration behind the principle he invented that became the basis for all blood counting solutions. This same drive to keep the science of hematology moving forward is behind Beckman Coulter's new ©Automated Intelligent Morphology© (AIM), a multidimensional,…
Founded in 1968, The Sysmex Corporation has challenged its way past far larger companies to become one of the leading healthcare companies around the world. How? By focusing constantly on one objective: maximising the strength of our people, knowledge and resourcefulness to live up to our mission statement: Shaping the Advancement of Healthcare.
Researchers from the University of Sheffield’s Department of Biomedical Science discovered the ultrasound transmits a vibration through the skin and wakes up cells in wounds helping to stimulate and accelerate the healing process.
The European Investment Bank (EIB) has provided a EUR 10 million long-term loan to Swedish biotech company Cavidi AB for developing a next generation automated testing device for HIV viral load. This is the first transaction under InnovFin Infectious Diseases, an innovative high risk-taking financial instrument recently established within the new generation of financial products for innovative…
Carestream is expanding into new imaging modalities: cone beam CT and ultrasound. Key advances in these areas will be demonstrated at the upcoming Association for Medical Imaging Management (AHRA) conference on July 19-22. For cone beam CT which is currently undergoing patient studies, a conceptual scale model will be on display.
Digitizing pathology is not just a transformation of technology, the major change and benefits lies in the change to a more efficient workflow – enabled by the new technology.
Vienna is the perfect place for a symposium dedicated to ‘hospital construction and operation because, over the next 15 years, the Austrian capital will radically transform its hospital landscape. In the facilities of the Municipal Hospital Association Vienna (Wiener Krankenanstaltenverband – KAV) 32,000 employees care for 400,000 in-patients annually, making KAV one of the largest hospital…
Clinical trials are under way at two NHS hospitals in England to assess breathalyser technology to detect lung cancer. Phase I clinical trials of a diagnostic breathalyser developed by Cambridge-based Owlstone Ltd have shown accurate identification of 12 lung cancer biomarkers in breath specimens. A Phase II trial is now targeting development of a small, handheld device that can be used in GP…
New figures for the UK’s key National Health Service (NHS) Trusts have revealed their total deficit of more than €1.1 billion for the year 2014-15. This rise on the previous year’s deficit of €160m comes against a backdrop of health authorities being required to find ‘efficiency savings’ of almost €1.4bn over the last five years. The NHS was also a major issue in the recent UK…
Unstable funding is threatening the viability of academic biomedical research, according to a new paper published this week in the journal Science Translational Medicine. The paper was written jointly by the deans of 19 prominent medical schools around the USA. Among this group is University of Maryland School of Medicine Dean E. Albert Reece.
Research published in the Proceedings of the National Academy of Sciences (PNAS) demonstrates that technology invented by researchers at Oregon Health & Science University’s Casey Eye Institute can improve the clinical management of the leading causes of blindness. Optical coherence tomography (OCT) angiography could largely replace current dye-based angiography in the management of these…
Henry Schein, a provider of health care products and services to office-based dental, animal health and medical practitioners, announced today the Company's commitment of $500,000 in product donations to support relief efforts for victims of the devastating earthquake in Nepal. In addition, the Company has opened the Henry Schein Cares Nepal Disaster Relief Fund through the Henry Schein Cares…
The USA’s President Barack Obama released a comprehensive plan in March to slow the emergence of drug-resistant bacteria, a multi-year, billion-dollar effort that includes getting doctors to stop over-prescribing antibiotics, developing new medications and rapid diagnostics, and real-time tracking of infection outbreaks. Report: Lisa Chamoff
Bio-Rad Laboratories, a global provider of life science research and clinical diagnostic products, announced that Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad's Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies.
Health apps have the potential to make a broad impact on the health of the general population, argues one expert in The BMJ this week. But another explains that there is not enough evidence to support such claims and suggests that health apps may even be harmful.
The question as to whether or not there is a point in using medical apps on private smartphones is being asked more frequently. Issues around medical diagnostics are among the key points here. We asked Prof. Dr. Dr. Norbert Gässler, Head of the Centre for Laboratory Diagnostics at the St. Bernward Hospital, Hildesheim, for competent advice. Interview: Walter Depner
